Solace Health, a patient advocacy platform, is expanding insurance coverage to most major health plans, including UnitedHealthcare and Anthem Blue Cross Blue Shield.
Solace previously connected Medicare and Medicare Advantage patients to its services, which are now also available to many commercially insured patients. Other commercial plans that are now partners were not specified in a press release. Solace pairs each patient with a dedicated healthcare advocate who helps with care navigation.
The healthcare system is complex and yet patients are often expected to coordinate their own care, interpret advice, manage records and resolve billing issues. One 2025 study found that over 60% of U.S. adults demonstrated inadequate health literacy. Solace aims to close this gap.
Solace CEO Jeremy Gurewitz and Chief Product Officer Sara Sargent founded the company in 2022 after Gurewitz’s mother was diagnosed with pancreatic cancer in 2016. Though his mother was a physician, the family still experienced difficulty navigating her care.
“No one should have to manage the healthcare system alone,” Gurewitz said in a press release. “Patients are expected to carry an unreasonable amount of administrative and emotional labor in the exact moments they are least equipped to do so. This expansion means millions more Americans can access a qualified advocate when they need one most.”
For every hour spent with a patient, Solace advocates spend additional hours coordinating care, handling insurance calls, scheduling appointments and tracking follow-up. Solace data show this resonates: 98% of patients feel more in control after working with a Solace advocate and 92% experience measurably better health outcomes, the company claims. The data is based on a 2023 report by the Coalition of Healthcare Advocacy Organizations.
Solace raised $130 million in a series C earlier this year, with investors IVP, Menlo Ventures, Torch Capital and others. The raise, which Solace hoped to use to expand its national advocate network, valued the company at $1 billion. As of February, Solace had 2,000 advocates and served over 20,000 patients a month.